Current Report Filing (8-k)
May 09 2023 - 11:37AM
Edgar (US Regulatory)
0001592057
false
0001592057
2023-05-09
2023-05-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section
13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report
(date of earliest event reported): May 9, 2023
Enviva
Inc.
(Exact name of registrant
as specified in its charter)
Delaware |
|
001-37363 |
|
46-4097730 |
(State
or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(I.R.S.
Employer Identification No.) |
7272
Wisconsin Ave., Suite 1800 Bethesda,
MD |
|
20814 |
(Address of principal executive offices) |
|
(Zip code) |
(301)
657-5560
Registrant’s
telephone number, including area code:
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common
Stock |
|
EVA |
|
New
York Stock Exchange |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth
company ¨
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 7.01. |
Regulation FD Disclosure. |
On
May 9, 2023, Enviva Inc. (the “Company”) posted an investor presentation to the Investor Relations section of its website
at www.envivabiomass.com. A copy of the presentation materials is being furnished as Exhibit 99.1 hereto and is incorporated herein
by reference.
The
information in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 is being “furnished” and shall not
be deemed to be “filed” by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference into
any filing under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01. | Financial Statements and Exhibits. |
Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 9, 2023
| ENVIVA INC. |
| | |
| By: | /s/ Jason E. Paral |
| Name: | Jason E. Paral |
| Title: | Senior Vice President,
General Counsel, and Secretary |
Enviva (NYSE:EVA)
Historical Stock Chart
From Jan 2025 to Feb 2025
Enviva (NYSE:EVA)
Historical Stock Chart
From Feb 2024 to Feb 2025